×
Please click
here
if you are not redirected within a few seconds.
All
Images
Videos
News
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
StockNews.com Begins Coverage on Bellerophon Therapeutics (NASDAQ:BLPH)
Defense World
Stock analysts at StockNews.com initiated coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Get Free Report) in a report...
4 days ago
Hilco Streambank Seeks Offers to Acquire Patent Portfolio and Material Inventory of Biotherapeutics Company ...
PR Newswire
PRNewswire/ -- Hilco Streambank (www.HilcoStreambank.com), a leading intellectual property advisory firm specializing in the valuation and...
4 months ago
Bellerophon whittles workforce, discontinues device development
Fierce Biotech
The New Jersey-based maker of the InoPulse gas therapy delivery device is ceasing operations and eliminating essentially its entire workforce as...
9 months ago
Bellerophon Shareholders Vote to Dissolve Amid Board Resignations - TipRanks.com
Tipranks
Bellerophon (BLPH) just unveiled an update. Bellerophon Therapeutics, Inc. is set to dissolve after a decisive shareholder vote favored the...
1 month ago
Bellerophon trial fails despite innovative digital endpoint
STAT
Bellerophon is abandoning a Phase 3 trial of its pulmonary fibrosis treatment after patients using a digital endpoint showed no improvement.
10 months ago
Why Is Bellerophon Therapeutics (BLPH) Stock Down 34% Today?
InvestorPlace
Bellerophon Therapeutics (BLPH) stock is losing value on Tuesday after the clinical-stage therapeutics company was sent a delisting notice.
8 months ago
Bellerophon's study of fILD therapy fails to meet primary endpoint
Clinical Trials Arena
Bellerophon Therapeutics has reported that its Phase III trial of INOpulse for interstitial lung disease failed to meet its primary...
10 months ago
Thinking about buying stock in BigBear.ai, Janux Therapeutics, Surf Air Mobility, Bank of Nova Scotia, or Bellerophon ...
KLFY.com
NEW YORK, Feb. 27, 2024 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BBAI, JANX, SRFM, BNS, and BLPH.
1 month ago
Bellerophon Therapeutics (BLPH) to Release Earnings on Friday
Defense World
Read Bellerophon Therapeutics (BLPH) to Release Earnings on Friday at Defense World.
3 weeks ago
Phase 3 trial of INOpulse for PF fails to meet primary, secondary...
Pulmonary Fibrosis News
The Phase 3 REBUILD clinical trial, which tested Bellerophon Therapeutics' inhaled nitric oxide therapy INOpulse in people with pulmonary...
10 months ago